Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
While cytoplasmic aggregation of TDP-43 is a pathological hallmark of amyotrophic lateral sclerosis and frontotemporal dementia, how aggregates form and what drives its nuclear clearance have not been determined.
|
30853299 |
2019 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Whereas wild-type UBQLN2 accumulates in intraneuronal deposits in several common age-related neurodegenerative diseases, mutations in the gene encoding this protein result in X-linked amyotrophic lateral sclerosis/frontotemporal dementia associated with TDP43 accumulation.
|
30333186 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
We present the case that preventing the misfolding of TDP-43 and/or enhancing its clearance represents the most important target for effectively treating ALS and frontotemporal dementia.
|
25652699 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We investigated the contribution of rare variants in seven genes of known relevance to dementias (β-amyloid precursor protein (APP), PSEN1/2, MAPT (microtubule-associated protein tau), fused in sarcoma (FUS), granulin (GRN) and TAR DNA-binding protein 43 (TDP-43)) to PD and PD plus dementia (PD+D) in a discovery sample of 376 individuals with PD and followed by the genotyping of 25 out of the 27 identified variants with a minor allele frequency <5% in 975 individuals with PD, 93 cases with Lewy body disease on neuropathological examination, 613 individuals with Alzheimer's disease (AD), 182 cases with frontotemporal dementia and 1014 general population controls.
|
25604855 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We interrogated pathological Alzheimer's disease (n = 247); other tauopathies (n = 95) including Pick's disease, corticobasal disease and progressive supranuclear palsy; the synucleinopathies (n = 164) including multiple system atrophy and Lewy body disease; the TDP-43 proteinopathies (n = 188) including frontotemporal lobar degeneration with TDP-43 inclusions and amyotrophic lateral sclerosis; and a minimal pathology group (n = 72).
|
29878075 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using an atomic force microscopy based biopanning protocol developed in our lab, we previously isolated 23 TDP-43 reactive antibody fragments with preference for human ALS brain tissue relative to frontotemporal dementia, a related neurodegeneration, and healthy samples from phage-displayed single chain antibody fragment (scFv) libraries.
|
28122516 |
2017 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Transactivation response element (TAR) DNA-binding protein 43 (TDP-43) is the principal component of ubiquitinated inclusions characteristic of most forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia-frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), as well as an increasing spectrum of other neurodegenerative diseases.
|
25503365 |
2014 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
This breakthrough provides an opportunity to re-evaluate longstanding concepts regarding the cause and natural history of ALS, coming soon after the pathological unification of ALS with frontotemporal dementia through a shared pathological signature of cytoplasmic inclusions of the ubiquitinated protein TDP-43.
|
23415570 |
2013 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings also document an association, in TDP43-proteinopathy patients, between heterogenous ribonucleoprotein pathology and RNA metabolism alterations and carry importance for neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
24462217 |
2014 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
There were no significant differences between clinical syndromes (PPA subtypes), the main clinical forms of dementia (frontotemporal dementia and AD), or the expected pathological groups (frontotemporal lobar degeneration-tau [FTLD-tau], FTLD-TDP43, and AD).
|
31640103 |
2019 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
There are no effective TDP-43-directed therapies for ALS or related TDP-43 proteinopathies, such as frontotemporal dementia.
|
28405022 |
2017 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The two major RNA Binding Proteins involved in Amyotrophic Lateral Sclerosisi and Frontotemporal Dementia are TDP-43 and FUST/TLS.
|
27015757 |
2016 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The scientific scenario of amyotrophic lateral sclerosis (ALS) has dramatically changed since TDP-43 aggregates were discovered in 2006 as the main component of the neuronal inclusions seen in the disease, and more recently, when the implication of C9ORF72 expansion in familial and sporadic cases of ALS and frontotemporal dementia was confirmed.
|
27236050 |
2016 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The RNA-binding protein TDP-43, associated to amyotrophic lateral sclerosis and frontotemporal dementia, regulates the alternative splicing of several genes, including the skipping of TNIK exon 15.
|
31382054 |
2019 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present study represents the first attempt to investigate the endocannabinoid system in an alternative model, the transgenic mouse model of TAR-DNA binding protein-43 (TDP-43), a protein related to ALS and also to frontotemporal dementia.
|
25819934 |
2015 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The human TAR DNA binding protein 43 (TDP-43), encoded by the gene TARDBP, plays a central role in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
|
25442115 |
2015 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The full definition of the physiological RNA targets regulated by TDP-43 and FUS RNA-binding proteins (RBPs) represents an important issue in understanding the pathogenic mechanisms associated to these two proteins in amyotrophic lateral sclerosis and frontotemporal dementia.
|
26514432 |
2015 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The TAR DNA-binding protein (TDP-43) self-assembles into prion-like aggregates considered to be the structural hallmark of amyotrophic lateral sclerosis and frontotemporal dementia.
|
31782904 |
2019 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The TAR DNA-binding protein-43 (TDP-43) has been identified as a major constituent of inclusions found in frontotemporal dementia with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS).
|
18634762 |
2008 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TDP-43 proteinopathy is a pathological hallmark of amyotrophic lateral sclerosis and frontotemporal dementia where cytoplasmic TDP-43 inclusions are observed within degenerating regions of patient postmortem tissue.
|
30826182 |
2019 |
Pick Disease of the Brain
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia.
|
27138926 |
2016 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recent evidence shows that TDP-43, a RNA-binding protein associated with frontotemporal dementia and amyotrophic lateral sclerosis, exists in a physiological and functional nuclear oligomeric form, whose destabilization may represent a prerequisite for misfolding, toxicity and subsequent pathological deposition.
|
29070802 |
2017 |
Pick Disease of the Brain
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
|
24309270 |
2014 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Phase-separated compartments can concentrate specific RNA-binding proteins (RBPs), such as TDP-43 and fused in sarcoma (FUS), that through low-complexity, prion-like domains have an intrinsic tendency to form self-templating fibrils that are closely tied to fatal neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
|
30948513 |
2019 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pathology showed typical PD-type Lewy body disease (LBD) in most patients, whereas in others there was 'pure' nigral degeneration (one with TDP-43-positive inclusions), diffuse LBD, or tau-, alpha-synuclein- or ubiquitin-positive pathology reminiscent of progressive supranuclear gaze palsy, multisystem atrophy, and frontotemporal dementia with ubiquitin-positive inclusions.
|
20197701 |
2010 |